Get the Stockscreener App
1.59
3.64%
-0.06
After Hours:
1.57
-0.02
-1.26%
Pliant Therapeutics Inc stock is traded at $1.59, with a volume of 478.39K.
It is down -3.64% in the last 24 hours and down -5.36% over the past month.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
See More
Previous Close:
$1.65
Open:
$1.67
24h Volume:
478.39K
Relative Volume:
0.43
Market Cap:
$97.61M
Revenue:
$5.03M
Net Income/Loss:
$-185.41M
P/E Ratio:
-0.5146
EPS:
-3.09
Net Cash Flow:
$-139.79M
1W Performance:
-14.52%
1M Performance:
-5.36%
6M Performance:
+0.63%
1Y Performance:
-86.57%
1-Day Range:
$1.56
$1.69
1-Week Range:
$1.56
$1.85
52-Week Range:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Name
Pliant Therapeutics Inc
Sector
Industry
Phone
650-481-6770
Address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Compare PLRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.59 | 103.75M | 5.03M | -185.41M | -139.79M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Resumed | Cantor Fitzgerald | Neutral |
| Mar-04-25 | Downgrade | Needham | Buy → Hold |
| Mar-03-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-03-25 | Downgrade | Stifel | Buy → Hold |
| Feb-10-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-10-25 | Downgrade | Citigroup | Buy → Neutral |
| Feb-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-10-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-10-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-10-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Dec-08-23 | Initiated | Wells Fargo | Overweight |
| May-18-23 | Initiated | Canaccord Genuity | Buy |
| Apr-13-23 | Initiated | Robert W. Baird | Outperform |
| Dec-14-22 | Initiated | Stifel | Buy |
| Dec-07-22 | Initiated | JP Morgan | Overweight |
| Sep-01-22 | Initiated | Citigroup | Buy |
| Jul-20-22 | Initiated | SVB Leerink | Outperform |
| May-25-22 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-10-21 | Initiated | Oppenheimer | Outperform |
| Nov-24-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | BTIG Research | Buy |
| Apr-05-21 | Initiated | Citigroup | Buy |
| Jun-29-20 | Initiated | Citigroup | Buy |
| Jun-29-20 | Initiated | Cowen | Outperform |
| Jun-29-20 | Initiated | Needham | Buy |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
View All
Pliant Therapeutics Inc Stock (PLRX) Latest News
Will Pliant Therapeutics Inc. stock outperform tech sector in 2025July 2025 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
Nuveen LLC Acquires New Stake in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Is Pliant Therapeutics Inc. benefiting from interest rate changesGDP Growth & Stock Market Timing Techniques - Lancaster City Council
Cormorant Asset Management LP Invests $4.05 Million in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Can Pliant Therapeutics Inc. navigate macro headwindsMarket Volume Summary & Proven Capital Preservation Tips - beatles.ru
Penny Stocks To Watch With Market Caps Under $700M - simplywall.st
Allostery Investments LP Invests $596,000 in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Is Pliant Therapeutics Inc. stock risky to hold nowPortfolio Value Summary & Daily Profit Maximizing Tips - beatles.ru
Redmile Group LLC Reduces Stock Holdings in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Pliant Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
What’s next for Pliant Therapeutics Inc. stock priceAnalyst Upgrade & Community Verified Watchlist Alerts - Newser
What analysts say about Pliant Therapeutics Inc. stockWeekly Trend Report & Free Long-Term Investment Growth Plans - خودرو بانک
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives $8.19 Average PT from Analysts - MarketBeat
Sector ETF performance correlation with Pliant Therapeutics Inc.Weekly Profit Report & AI Based Buy and Sell Signals - Newser
Is Pliant Therapeutics Inc. stock entering bullish territoryPrice Action & Verified High Yield Trade Plans - Newser
Pliant Therapeutics Inc. stock volume spike explainedGap Up & Free Expert Approved Momentum Trade Ideas - Newser
What’s the profit margin of Pliant Therapeutics Inc.2025 Price Momentum & Trade Opportunity Analysis - خودرو بانک
Strategies to average down on Pliant Therapeutics Inc.2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Institutional scanner results for Pliant Therapeutics Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
Published on: 2025-09-05 06:24:37 - Newser
Why Pliant Therapeutics Inc. is moving todayJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Live market analysis of Pliant Therapeutics Inc.Index Update & Free Low Drawdown Momentum Trade Ideas - Newser
How to build a custom watchlist for Pliant Therapeutics Inc.2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Is Pliant Therapeutics Inc. forming a bottoming base2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Analyzing drawdowns of Pliant Therapeutics Inc. with statistical toolsJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Relative strength of Pliant Therapeutics Inc. in sector analysis2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
Does Pliant Therapeutics Inc. stock have upside surprise potentialJuly 2025 PostEarnings & Weekly Breakout Watchlists - خودرو بانک
How cyclical is Pliant Therapeutics Inc.’s revenue stream2025 Retail Activity & Capital Efficiency Focused Ideas - خودرو بانک
Pliant Therapeutics Inc. stock trendline breakdownWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Live market analysis of Pliant Therapeutics IncJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
What Fibonacci levels say about Pliant Therapeutics Inc. rebound2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Pliant Therapeutics Inc. stock split in the near future2025 Top Decliners & AI Powered Trade Plan Recommendations - Newser
How to use Fibonacci retracement on Pliant Therapeutics Inc.New Guidance & Free Technical Pattern Based Buy Signals - Newser
How to forecast Pliant Therapeutics Inc. trends using time seriesMarket Weekly Review & Momentum Based Trading Ideas - Newser
Is Pliant Therapeutics Inc. meeting your algorithmic filter criteria2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Sentiment analysis tools applied to Pliant Therapeutics Inc.2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
Can swing trading help recover from Pliant Therapeutics Inc. lossesTrade Risk Assessment & Precise Trade Entry Recommendations - Newser
Can Pliant Therapeutics Inc. rally from current levelsQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Is Pliant Therapeutics Inc. stock poised for growthMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
How to recover losses in Pliant Therapeutics Inc. stockQuarterly Growth Report & Accurate Trade Setup Notifications - Newser
Will Pliant Therapeutics Inc. announce a stock splitProfit Target & Low Risk High Reward Trade Ideas - خودرو بانک
How to track smart money flows in Pliant Therapeutics Inc.Market Trend Review & Free Technical Confirmation Trade Alerts - Newser
Pliant Therapeutics Inc Stock (PLRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):